The Albert II Institute of the Saint-Luc University Clinics in Brussels is a reference in Europe and a leader in French-speaking Belgium for the treatment of adult and child cancers. In addition to clinical care, the institute stands out for its cutting-edge research and teaching activities.
The construction of the Institute's new building was awarded to Wust, a BESIX Group subsidiary, and Moury. It will enable the oncology and haematology activities to be grouped together in a single building of approximately 20,000 m².
Work began in January, with completion of the structural work scheduled for 2023 and opening in 2024.